The effects of anagliptin on plasma lanosterol, sitosterol, campesterol level in patients with type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2014
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 23 Jul 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 24 Apr 2014 Planned End Date changed to 1 Jun 2014 as reported by University Hospital Medical Information Network - Japan record.
- 08 Aug 2013 New trial record